XML 18 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Condensed Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 28, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net income $ 138,575 $ 16,042
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation of property, plant and equipment 97,172 124,556
Amortization of definite-lived intangible assets 34,209 41,807
Amortization of debt discount and issuance costs 14,488 10,764
Deferred income taxes 8,039 (2,453)
Stock-based compensation 11,961 12,190
Impairment of goodwill 69,200  
Gain on sale of the Mobility business unit (237,253)  
Other (242) (2,592)
Changes in operating assets and liabilities:    
Accounts receivable, net 128,681 (6,777)
Contract assets (33,500) 19,199
Inventories (10,557) (16,947)
Prepaid expenses and other current assets (15,008) (6,049)
Accounts payable 15,902 21,435
Contract liabilities (839) (473)
Accrued salaries, wages and benefits (11,804) (12,374)
Other current liabilities 22,661 (16,539)
Net cash provided by operating activities 231,685 181,789
Cash flows from investing activities:    
Proceeds from sale of the Mobility business unit, net of cash disposed 507,466  
Purchase of property, plant and equipment and other assets (84,042) (95,372)
Proceeds from sale of property, plant and equipment and other assets 154 6,382
Other (623)  
Net cash provided by (used in) investing activities 422,955 (88,990)
Cash flows from financing activities:    
Repayment of long-term debt borrowing (400,000) (30,000)
Proceeds from exercise of stock options 191  
Payment of debt issuance costs   (1,639)
Redemption of convertible notes   (10)
Other 7,321  
Net cash used in financing activities (392,488) (31,649)
Effect of foreign currency exchange rates on cash, cash equivalents, and restricted cash 979 (921)
Net increase in cash, cash equivalents, and restricted cash 263,131 60,229
Cash, cash equivalents, and restricted cash at beginning of period 400,154 256,360
Cash, cash equivalents, and restricted cash at end of period 663,285 316,589
Cash, cash equivalents, and restricted cash in assets held for sale   (20,230)
Cash, cash equivalents, and restricted cash as presented on the consolidated condensed balance sheet 663,285 296,359
Supplemental cash flow information:    
Cash paid, net for interest 40,540 58,319
Cash paid, net for income taxes 15,856 12,367
Net cash provided by operating activities from discontinued operations 39,462 12,218
Net cash provided by (used in) investing activities from discontinued operations 497,916 (20,356)
Supplemental disclosure of noncash investing activities:    
Property, plant and equipment recorded in accounts payable $ 26,914 66,681
Supplemental disclosure of noncash investing activities from discontinued operations:    
Property, plant and equipment recorded in accounts payable   $ 10,495